Repository logo
 
Publication

Prostatic Arterial Embolization to Treat Benign Prostatic Hyperplasia

2011Journal article Open access
Simple item page
dc.contributor.authorPisco, JM
dc.contributor.authorPinheiro, LC
dc.contributor.authorBilhim, T
dc.contributor.authorDuarte, M
dc.contributor.authorMendes, J
dc.contributor.authorOliveira, A
dc.date.accessioned2013-03-27T17:21:26Z
dc.date.available2013-03-27T17:21:26Z
dc.date.issued2011
dc.description.abstractPURPOSE: To evaluate whether prostatic arterial embolization (PAE) might be a feasible procedure to treat lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: Fifteen patients (age range, 62-82 years; mean age, 74.1 y) with symptomatic BPH after failure of medical treatment were selected for PAE with nonspherical 200-μm polyvinyl alcohol particles. The procedure was performed by a single femoral approach. Technical success was considered when selective prostatic arterial catheterization and embolization was achieved on at least one pelvic side. RESULTS: PAE was technically successful in 14 of the 15 patients (93.3%). There was a mean follow-up of 7.9 months (range, 3-12 months). International Prostate Symptom Score decreased a mean of 6.5 points (P = .005), quality of life improved 1.14 points (P = .065), International Index of Erectile Function increased 1.7 points (P = .063), and peak urinary flow increased 3.85 mL/sec (P = .015). There was a mean prostate-specific antigen reduction of 2.27 ng/mL (P = .072) and a mean prostate volume decrease of 26.5 mL (P = .0001) by ultrasound and 28.9 mL (P = .008) by magnetic resonance imaging. There was one major complication (a 1.5-cm(2) ischemic area of the bladder wall) and four clinical failures (28.6%). CONCLUSIONS: In this small group of patients, PAE was a feasible procedure, with preliminary results and short-term follow-up suggesting good symptom control without sexual dysfunction in suitable candidates, associated with a reduction in prostate volume.por
dc.identifier.citationJ Vasc Interv Radiol. 2011 Jan;22(1):11-9; quiz 20por
dc.identifier.urihttp://hdl.handle.net/10400.17/1193
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherElsevierpor
dc.subjectArtériaspor
dc.subjectBiópsiapor
dc.subjectEmbolização Terapêuticapor
dc.subjectEfeitos Adversospor
dc.subjectEstudos de Viabilidadepor
dc.subjectIsquemiapor
dc.subjectRessonância Magnéticapor
dc.subjectTamanho do Órgãopor
dc.subjectErecção do Pénispor
dc.subjectProjectos Pilotopor
dc.subjectÁlcool de Polivinilpor
dc.subjectPortugalpor
dc.subjectEstudos Prospectivospor
dc.subjectPróstatapor
dc.subjectUltrassonografiapor
dc.subjectAntigénio Prostático Específicopor
dc.subjectHiperplasia Prostáticapor
dc.subjectQualidade de Vidapor
dc.subjectRecuperação da Função Fisiológicapor
dc.subjectFactores de Tempopor
dc.subjectResultado de Tratamentopor
dc.subjectBexigapor
dc.subjectUrodinâmicapor
dc.titleProstatic Arterial Embolization to Treat Benign Prostatic Hyperplasiapor
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage19por
oaire.citation.startPage11por
oaire.citation.titleJournal of Vascular and Interventional Radiologypor
rcaap.rightsopenAccesspor
rcaap.typearticlepor

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
JVIR 2011 11.pdf
Size:
1.78 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

URO - Artigos